IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |
| Parkman Healthcare Partners LLC | 159,503 | $7,235,056 | 1.33% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 46,500 | $2,109,240 | 1.31% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,072,000 | 1.28% |
| HighVista Strategies LLC | 48,520 | $2,200,867 | 1.02% |
| Eversept Partners, LP | 252,446 | $11,450,951 | 0.97% |
| AtonRa Partners | 9,329 | $423,163 | 0.89% |
| ARK Investment Management | 2,366,367 | $107,338,401 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 43,000 | $1,949,190 | 0.66% |
| Sonora Investment Management Group, LLC | 148,450 | $6,733,692 | 0.58% |
| ALTRINSIC GLOBAL ADVISORS LLC | 292,184 | $13,253,466 | 0.51% |
External links
This page lists IONIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view IONIS PHARMACEUTICALS INC's shareholder history, click here.